Combined protective effect of an immunostimulatory bacterial preparation and rimantadine in experimental influenza A virus infection

Acta Virologica

Volumn 41, Issue 2, 1997, Pages 65-70

  Serkedjieva, J ^a   Ivanova, E ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Bacterial cytoplasmic membranes; Combined protective effect; Experimental influenza infection; Rimantadine

Indexed keywords

IMMUNOMODULATING AGENT; RIMANTADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; IMMUNOMODULATION; INFLUENZA; INFLUENZA VIRUS A; LUNG; MALE; MORTALITY; MOUSE; NONHUMAN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ESCHERICHIA COLI; FEMALE; INFLUENZA A VIRUS; MALE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RIMANTADINE;

EID: 0030777625     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Arrora DJS (1993): Enhanced natural resistance protects mice against lethal influenza. In Abstracts of the 9th Congress of Virology. Glasgow, Scotland, August 8-13, 1993, p. 165, N P15-26.
2. Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ (1988): Genetic bases of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 62, 1508-1512.
3. Carrano RA, Iulliucci JD, Luce JK, Page JA, Imondi AR (1984): Development of an immunoadjuvant for cancer treatment. In Fenckel RL, Chirigos MA (Eds): Immune Modulation Agents and Their Mechanism. Marcel Decker, New York, pp. 243-260.
4. Cibulski AV, Isackova LM, Ovodova RG, Glazkova BE, Besednova NN, Orlova TG (1990): Effect of methylan - bioglycan from Grenomytilus grayanus on experimental influenza infection. Vopr. Virusol. 3, 194-198 (in Russian).
5. D'Agostini C, Palamara AT, Favalli C, Sivilia M, Febbraro G, Bue C, Garaci E (1996): Efficacy of combination therapy with amantadine, thymosin α1 and α/β interferon in mice. Int. J. Immunopharmacol. 18, 95-102.
6. Dolin R, Reichman RC, Madora HP, Maynard R, Linton PN (1982): A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New Engl. J. Med. 307, 580-584.
7. Garaci E, Rocchi G, Perroni L, D' Agostini C, Soscia F, Greli S, Mastino A, Favalli C (1994): Combination treatment with zidovudine, thymosin α1 and interferon-α in human immunodeficiency virus infection. Int. J. Clin. Lab. Res. 24, 23-28.
8. + and its stable protoplast type L-form. Zeitschrift. Allg. Mikrobiol. 22(3), 109-114.
9. Hayden FG, Couch RB (1992): Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimantadine. Rev. Med. Virol. 2, 89-96.
10. Herrmann JE, West K, Bruns M, Ennis FA (1990): Effect of rimantadine on cytotoxic T lymphocyte responses and immunity to reinfection in mice infected with influenza A virus. J. Infect. Dis. 161, 180-184.
11. Ilienko VI (1977): In Methods of Evaluation and Estimation of the Antiviral Activity of Chemotherapeutic Substances in Respect to Influenza Infection. Institute of Influenza, Leningrad, pp. 23-30 (in Russian).
12. Irinoda K, Masihi KN, Chihara G, Kaneko Y, Tatsuhiko K (1992): Stimulation of microbial host defence mechanisms against aerosol influenza virus infection by lentinan. Int. J. Immunopharm. 14, 971-977.
13. Ivanova E (1986): Use of bacterial L-form cytoplasmic membranes as immunostimulants. Patent No. 43880, Reg. No. 75653.
14. Ivanova E, Toshkova R, Gumpert J, Penev M (1991): Effect of E. coli L-form cytoplasmic membranes on experimentally induced diseases. Comptes Rendus Acad. Bulg. Sci. 44(2), 51-54.
15. Ivanova E, Toshkova R, Serkedjieva J, Gumpert J (1992): Stimulating effect of Escherichia coli WF' L-form cytoplasmic membranes on the macrophage function of influenza infected mice. Comptes Rendus Acad. Bulg. Sci. 4(1), 85-88.
16. Ivanova E, Vesselinova A, Gumpert J (1993): Toxic and pyrogenic properties of Escherichia coli WF' L-form cytoplasmic membranes. Comptes Rendus Acad. Bulg. Sci. 46(6), 85-88.
17. Maltzeva AI, Agranovskaya EN, Zalicenok JM, Schwarzman JS (1973): Reproduction of influenza viruses in tissue cultures of chorioallantoic membranes from hens' embryos, attached to shells. Laboratornoe Delo 11, 689-690 (in Russian).
18. Masihi KN, Brehner W, Lange W, Ribi E (1983): Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection. Int. J. Immunopharmacol. 5, 403-410.
19. Michailova L, Ivanova E, Gumpert J, Toshkov AS, Jordanova M (1984): Immunoelectron microscopical determination of O-antigen in the stable protoplast type L-form of E. coli WF'. Comptes Rendus Acad. Bulg. Sci. 37(1), 77-80.
20. Osborn MJ, Gander JE, Parisie E, Carson J (1972): Mechanism of assembly of the outer membrane. II. Site of synthesis of lipopolysaccharide. J. Biol. Chem. 247, 3973-3986.
21. Pancheva S, Gegova G, Maximiva V, Manolova N (1990): Antiinfluenza effect of rimantadine and isoprinosine applied in combination in mice. Acta Microbiol. Bulg. 26, 26-29 (in Bulgarian).
22. Roberts NJ Jr (1988): The concept of immunofocusing illustrated by influenza virus infection. Rev. Infectious Dis. 10(6), 1071-1074.
23. Roberts NJ Jr, Domurat F (1989): Virus-induced immunosuppression: influenza virus. In Speeter S, Bendinelli M, Fried- man H (Eds): Virus-Induced Immunosuppression. Plenum Press, New York, pp. 303-326.
24. Reed LJ, Muench H (1938): A simple method of estimating fifty per cent end points. Am. J. Hyg. 27, 493-498.
25. Sidwell RW, Smee DF, Huffman JH, Bailey KW, Warren RP, Burger RA, Penney CL (1995): Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog. Antiviral Res. 26, 145-159.
26. Toshkova R, Ivanova E, Serkedjieva J, Gumpert J (1992): Effect of membrane associated lipopolysaccharide on the poly- morphonuclear functions of influenza infected mice. Comptes Rendus Acad. Bulg. Sci. 45(3), 103-106.
27. Van Voris LP, Betts RF, Hayden FG, Christmas WA, Douglas RG Jr (1981): Successful treatment of natural occuring influenza A/USSR/77 (H1N1). J. Am. Med. Assoc. 245, 1128-1131.
28. Webb L (1966): Inhibitors of Enzymes and Metabolism (General Principles of Inhibition). Mir Publishing House, Moscow, p. 484 (in Russian).